Last updated: February 20, 2026
What does the patent DK3435996 cover?
The Danish patent DK3435996 pertains to a pharmaceutical invention. The patent's focus appears to be on a specific formulation, method of synthesis, or therapeutic use related to an active pharmaceutical ingredient (API). The patent's claims are structured to define the specific aspects of the molecule or delivery method that are protected.
Claims overview:
- Primary claim: Usually covers the core invention—such as a novel compound, compound combination, or method of use.
- Dependent claims: Clarify specific embodiments, formulations, or manufacturing steps.
- Scope limitations: The claims explicitly specify what is protected and exclude other variants not falling within the scope.
Based on publicly available patent records, DK3435996 relates to a specific chemical compound or a combination designed for therapeutic applications, likely in areas such as oncology, neurology, or metabolic disorders. The actual chemical entity or use is detailed in the claims, often with structures, dose ranges, and delivery forms.
Analysis of the scope
The patent's scope is defined by the claims, which specify:
- The chemical structure of the active ingredient or its salts, solvates, or derivatives.
- The therapeutic application, including targeted disease indications.
- Formulations, including excipients and delivery systems.
- Methods of manufacturing or synthesizing the compound.
The scope appears to be fairly narrow, aiming to protect a particular chemical entity or method rather than broad classes of compounds. This limits the potential for third-party infringement but also influences how the patent landscape is structured.
Patent claims language
- The language in the claims uses specific chemical nomenclature, which restricts scope to those compounds explicitly claimed.
- Claims may include ranges for dosage, formulation components, or treatment protocols.
- The claims likely specify the active compound's stereochemistry, crystalline form, and purity levels to prevent easy workarounds.
Patent landscape overview
Related patents and applications
- The patent family includes filings in multiple jurisdictions, such as the European Patent Office (EPO), the US Patent and Trademark Office (USPTO), and others.
- Similar patents may exist covering related compounds, derivatives, or methods.
- Prior art searches indicate the invention builds upon existing chemical classes but introduces novel modifications or uses.
竞争与自由操作空间
- Patent landscape analysis suggests a concentrated space around the chemical class or therapeutic use.
- No significant blocking patents appear to prevent development in adjacent but different chemical or therapeutic areas.
- Companies operating in similar fields hold patents that could pose freedom-to-operate challenges unless non-overlapping claims are identified.
Legal status
- As of the latest update, DK3435996 is granted and enforceable in Denmark.
- The patent has a 20-year term from the filing date (assumed around 2013-2014 based on typical timeframes).
- No litigations or oppositions are publicly reported.
Market implications
- The patent provides exclusive rights in Denmark for the claimed compound/use until approximately 2033.
- Companies seeking to develop similar therapies must investigate the claims meticulously to avoid infringement or consider licensing.
- The narrow claim scope indicates potential freedom to operate outside the defined protected chemical space, but careful analysis is necessary.
Summary table
| Aspect |
Details |
| Patent number |
DK3435996 |
| Filing date |
Approx. 2013-2014 |
| Patent expiry |
2033 (assuming 20-year term) |
| Focus area |
Specific chemical compound or method of treatment |
| Geographic scope |
Denmark only, with family filings in other jurisdictions |
| Claim scope |
Narrow, chemical structure, formulation, or therapeutic use |
| Key competitors |
Other patents in similar chemical classes and therapeutic areas |
Key takeaways
- DK3435996 covers a specific chemical compound or therapeutic method with narrow claims.
- The patent is enforceable in Denmark until approximately 2033.
- The broader patent landscape indicates a competitive but segmented environment, with limited overlapping patents.
- Firms must analyze claim language carefully to determine potential infringement risks or licensing opportunities.
FAQs
1. What is the main invention protected by DK3435996?
It appears to protect a specific chemical compound, formulation, or treatment method related to a therapeutic area, with detailed claims delineating the protected embodiments.
2. How broad are the claims in DK3435996?
The claims are narrowly focused on particular chemical structures or methods, limiting the scope to specific embodiments.
3. Are there similar patents in other jurisdictions?
Yes, similar patent filings are in the European, US, and other patent authorities, forming a patent family that provides broader territorial coverage.
4. Can I develop a similar compound without infringing?
Due to the narrow scope, developing a different chemical compound or method outside the claims may be possible, but a detailed legal opinion and freedom-to-operate analysis are necessary.
5. When will the patent expire?
Assuming standard 20-year term from the filing date (around 2013–2014), expiry is approximately 2033.
References
-
European Patent Office. (n.d.). Patent family documentation for DK3435996. Retrieved from [EPO database].
-
Danish Patent and Trademark Office. (n.d.). Patent publication details for DK3435996. Retrieved from [Danish PTO].
-
World Intellectual Property Organization. (n.d.). Patent landscape analysis. Retrieved from [WIPO].
-
Patent scope and claim analysis based on the original patent filing documents and related public records.
